This is general Intellectual Property (Patent) Magazine. .... MOVED ... www.IntellZine.com The focus of this blog is on IP, innovation and especially on patent commercialization.
Tuesday, April 16, 2013
Oxycontin Expires today, April 16 2013. The “Patent Cliff” is not here on this one.
» The “Patent Cliff” and its Effects upon Workers’ Compensation Claims:
The Oxycontin patent expires today.
So you would expect to be able to buy many people's favorite drug on the side of the road or on hill-tops, just above cliff level.
As with many things that are FDA approved and regulated, this is going to be a very slow ride down from the cliff, definitely not a one-time drop off.
First, this drug is highly abused and strongly regulated by the FDA. The FDA will have to approve any other generic drug... And the new (non-new) generic version will be regulated along with Oxycontin.
The manufacturer, Purdue, is trying to get a 6 month extension on the patent, in part because of tamper-proof nature of the way they think the drug should be sold in the future.
In short, the downward slope of the Oxycontin slope is not a cliff. It is not a Black Diamond. It is probably going to be more of a bunny slope... With not much competition and higher prices for several years.
Of course, if you are buying it on the black market, you wouldn't want a knock off, right?
'via Blog this'
Labels:
drugs,
FDA,
patent cliff,
patent extension,
Patents
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment